Sr. Principal Process Engineer - ADN Ramp Team at Eli Lilly and Company

Indianapolis, Indiana, United States

Apply Now

$114,000 – $198,000Compensation

Senior (5 to 8 years), Expert & Leadership (9+ years)Experience Level

Full TimeJob Type

UnknownVisa

Pharmaceuticals, HealthcareIndustries

Requirements

Strong understanding of peptide API process engineering fundamentals
Experience with safe, right-first-time delivery and on-time facility start-up
Expertise in unit operations, Process Safety Management, and operational readiness
Ability to provide consultation and technical problem-solving related to Peptide API manufacturing
Root cause analysis techniques
Strong collaboration and coaching skills

Responsibilities

Provide Peptide API process engineering expertise to the Global Facility Delivery team and the Site Process Engineering team
Partner with site engineering teams to offer consultation and technical problem-solving
Coach and develop local technical team capabilities to accelerate operational excellence and technical skills
Utilize root cause analysis techniques to investigate process and equipment issues and deliver robust and sustainable corrective and preventative actions
Support site startup through direct technical execution, coaching next employees, and strong collaboration
Contribute to the development of strategies to help other new Lilly sites start up faster

Skills

Peptide API

Process Engineering

Unit Operations

Process Safety Management

Operational Readiness

Root Cause Analysis

Technical Problem-Solving

Eli Lilly and Company

Develops and delivers prescription medicines globally

About Eli Lilly and Company

Eli Lilly and Company is a global pharmaceutical company that focuses on discovering, developing, and delivering medicines to improve health. The company has a long history of scientific achievements, including the creation of insulin, the first life-saving treatment for diabetes. Lilly's operations involve extensive research and development to create new medications and enhance existing ones, ensuring they are safe and effective. Their products are primarily prescription medicines sold to healthcare providers for various medical conditions, including diabetes, cancer, and pain management. What sets Lilly apart from its competitors is its strong commitment to ethical practices and the protection of its products from counterfeiting. The company's goal is to enhance lives through innovative medical solutions while maintaining high standards of quality and ethics.

Indianapolis, IndianaHeadquarters

1876Year Founded

$1,180.1MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

10,001+Employees

Risks

Competition from Novo Nordisk's Ozempic may impact tirzepatide's market share.

Potential construction delays in Indiana could affect GLP-1 drug production timelines.

Regulatory challenges may hinder Kisunla's expansion in new Alzheimer's markets.

Differentiation

Eli Lilly's rich history includes the first life-saving insulin treatment.

Lilly's strategic partnerships enhance its position in neurodegenerative disease treatments.

FDA approval of Zepbound opens new therapeutic markets for sleep disorder treatments.

Upsides

Lilly's $9 billion complex in Indiana boosts GLP-1 drug production capacity.

Kisunla's approval in China expands Lilly's Alzheimer's treatment market in Asia.

Collaboration with EVA Pharma enhances Lilly's reputation as socially responsible.

Land your dream remote job 3x faster with AI

Try Jobo Free